PPARGC1A and chronic obstructive pulmonary disease: Finally, a recent study evidenced elevated circulating kynurenine levels in COPD patients, as well as reduced muscle levels of kynurenine aminotransferases; this dysregulated kynurenine clearance was attributed to impaired PGC1α signaling [145].